HDAC9 and breast carcinoma: These findings highlight how HDAC phosphorylation affects HDAC inhibitor binding and selectivity, and underscore the significance of JNK-HDAC3 axis in -breast- cancer clinical management and therapy [66,140,141,142,143,144,145,146].